pergolide has been researched along with Weight Gain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiarelli, F; Galluzzi, F; La Cauza, F; Salti, R; Stagi, S | 1 |
| Barget, M; Debilly, B; Derost, PP; Durif, F; Lemaire, JJ; Llorca, PM; Morand, D; Ouchchane, L; Ulla, M | 1 |
| Adams, ER; Carlson, KH; Francis, PC; Owen, NV | 1 |
3 other study(ies) available for pergolide and Weight Gain
| Article | Year |
|---|---|
Reversible weight gain and prolactin levels--long-term follow-up in childhood.
Topics: Adolescent; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Weight Gain | 2005 |
Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?
Topics: Activities of Daily Living; Age Factors; Aged; Antiparkinson Agents; Bipolar Disorder; Catechols; Cognition; Combined Modality Therapy; Communication; Deep Brain Stimulation; Dysarthria; Electrodes, Implanted; Emotions; Female; Humans; Levodopa; Male; Middle Aged; Movement; Neuropsychological Tests; Nitriles; Parkinson Disease; Pergolide; Prejudice; Quality of Life; Severity of Illness Index; Subthalamic Nucleus; Treatment Outcome; Weight Gain | 2007 |
Preclinical toxicology studies with the new dopamine agonist pergolide. Acute, subchronic, and chronic evaluations.
Topics: Administration, Oral; Animals; Behavior, Animal; Blood Cell Count; Diet; Dogs; Female; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Organ Size; Pergolide; Rabbits; Rats; Rats, Inbred F344; Rats, Wistar; Species Specificity; Time Factors; Weight Gain | 1994 |